Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.
Jones WS, Hellkamp AS, Halperin J, Piccini JP, Breithardt G, Singer DE, Fox KA, Hankey GJ, Mahaffey KW, Califf RM, Patel MR. Jones WS, et al. Among authors: califf rm. Eur Heart J. 2014 Jan;35(4):242-9. doi: 10.1093/eurheartj/eht492. Epub 2013 Dec 2. Eur Heart J. 2014. PMID: 24302273 Free article. Clinical Trial.
Restenosis: the cost to society.
Califf RM. Califf RM. Am Heart J. 1995 Sep;130(3 Pt 2):680-4. doi: 10.1016/0002-8703(95)90306-2. Am Heart J. 1995. PMID: 7668217 Review.
An overview of the results of the EPIC trial.
Califf RM, Lincoff AM, Tcheng JE, Topol EJ. Califf RM, et al. Eur Heart J. 1995 Nov;16 Suppl L:43-9. doi: 10.1093/eurheartj/16.suppl_l.43. Eur Heart J. 1995. PMID: 8869018 Clinical Trial.
Predictors of outcome of reperfusion therapy.
Califf RM, Lee KL, Granger CB, Ohman EM. Califf RM, et al. Eur Heart J. 1997 May;18(5):728-35. doi: 10.1093/oxfordjournals.eurheartj.a015338. Eur Heart J. 1997. PMID: 9152643 Review.
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F. Cohen M, et al. Among authors: califf rm. N Engl J Med. 1997 Aug 14;337(7):447-52. doi: 10.1056/NEJM199708143370702. N Engl J Med. 1997. PMID: 9250846 Free article. Clinical Trial.
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Mahaffey KW, Granger CB, Toth CA, White HD, Stebbins AL, Barbash GI, Vahanian A, Topol EJ, Califf RM. Mahaffey KW, et al. Among authors: califf rm. J Am Coll Cardiol. 1997 Dec;30(7):1606-10. doi: 10.1016/s0735-1097(97)00394-x. J Am Coll Cardiol. 1997. PMID: 9385883 Free article. Clinical Trial.
Myonecrosis after revascularization procedures.
Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM. Califf RM, et al. J Am Coll Cardiol. 1998 Feb;31(2):241-51. doi: 10.1016/s0735-1097(97)00506-8. J Am Coll Cardiol. 1998. PMID: 9462562 Free article. Review.
1,320 results